WO2002084336A2 - Optical pressure monitoring system - Google Patents

Optical pressure monitoring system Download PDF

Info

Publication number
WO2002084336A2
WO2002084336A2 PCT/US2001/051498 US0151498W WO02084336A2 WO 2002084336 A2 WO2002084336 A2 WO 2002084336A2 US 0151498 W US0151498 W US 0151498W WO 02084336 A2 WO02084336 A2 WO 02084336A2
Authority
WO
WIPO (PCT)
Prior art keywords
tube
optical signal
infusion set
abutment member
signal receiver
Prior art date
Application number
PCT/US2001/051498
Other languages
French (fr)
Other versions
WO2002084336A3 (en
Inventor
James A. Malmstrom
Kent F. Beck
Scott D. Miles
Original Assignee
Zevex, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zevex, Inc. filed Critical Zevex, Inc.
Priority to EP01273542.9A priority Critical patent/EP1381889B1/en
Priority to JP2002582033A priority patent/JP4143414B2/en
Priority to AU2001297726A priority patent/AU2001297726A1/en
Publication of WO2002084336A2 publication Critical patent/WO2002084336A2/en
Publication of WO2002084336A3 publication Critical patent/WO2002084336A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/16854Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01LMEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE
    • G01L9/00Measuring steady of quasi-steady pressure of fluid or fluent solid material by electric or magnetic pressure-sensitive elements; Transmitting or indicating the displacement of mechanical pressure-sensitive elements, used to measure the steady or quasi-steady pressure of a fluid or fluent solid material, by electric or magnetic means
    • G01L9/0001Transmitting or indicating the displacement of elastically deformable gauges by electric, electro-mechanical, magnetic or electro-magnetic means
    • G01L9/0007Transmitting or indicating the displacement of elastically deformable gauges by electric, electro-mechanical, magnetic or electro-magnetic means using photoelectric means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/0482Enteral feeding product
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3306Optical measuring means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3351Controlling upstream pump pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3355Controlling downstream pump pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14212Pumping with an aspiration and an expulsion action
    • A61M5/14232Roller pumps

Definitions

  • the present invention relates to systems for feeding solutions to patients. More particularly, the present invention relates to a system and method for monitoring fluid pressures to ensure that the solution is properly fed to the patient by the enteral feeding pump or similar device. Specifically, the invention relates to the use of optical pressure sensors to monitor fluid pressures and the presence of occlusions in the delivery set which may interfere with solution flow to the patient, and so that operation of the enteral feeding pump may be modified to compensate for the pressure and/or occlusion and thereby provide highly accurate solution delivery.
  • parenteral solutions are often necessary to hydrate the patient, or supply needed medications, occlusion of the infusion delivery set can be particularly dangerous to the patient. Thus, it is important to ensure that occlusions are not impeding solution flow.
  • parenteral solutions typically have a very low viscosity in order to faciliate absorption into the blood stream. Therefore, the risk of occlusion of the infusion set is relatively small so long as the tube is not pinched shut by folding or some other external application of force.
  • an enteral feeding system is used to provide nutrient solutions to patients who, for one reason or an other, are unable to eat for themselves .
  • Such a system typically includes a pump which is attached to an input tube connected to a supply container and to an output tube which is connected to a patient.
  • the pump draws nutrient solution from the supply container and delivers the solution to the patient.
  • an enteral feeding pump can adjust its output to deliver a predetermined amount of nutrient solution (or even medication) at a desired rate.
  • a significant problem with currently available enteral feeding systems is that the intake and output tubes may become occluded.
  • enteral feeding solutions have a relatively high viscosity, as they must carry sufficient nutrition to sustain the patient. Occlusion can occur, for example, if a fibrous substance is included in the enteral feeding solution and somehow combines to interfere with flow through the tube. Occlusion can also occur if a tube is bent sufficiently to interfere with flow therethrough, or if a roller clamp (as is commonly used for intravenous applications) is not sufficiently opened. Because of the viscosity of the solution, the amount of kinking of the tube or other interference required to interfere with solution flow is significantly less than that required in a parenteral infusion set . If the intake tube becomes occluded, insufficient solution may be supplied to the pump, and thus to the patient.
  • enteral feeding systems Yet another concern with enteral feeding systems is that of viscosity of the solution and viscosity changes as a container full of solution is pumped to a patient. Knowing the viscosity of the fluid being pumped through the enteral feeding system is important because different viscosities are pumped at different rates by the enteral feeding pump. For example, a lower quantity of a highly viscous solution will be pumped by a given number of rotations of the enteral feeding pump motor than will be moved by the same pump when the solution has low viscosity. In other words, the amount of solution fed to the patient can differ substantially depending on the solution's viscosity. Thus, unless the pump is able to accurately determine and compensate for viscosity changes in the solution (i.e. by increasing or decreasing the rotations of the pump rotor in a given period of time) , it is difficult to know exactly how much of the solution has been fed to the patient.
  • U.S. Patent No. 5,720,721 (February 24, 1998), which is expressly incorporated herein, provides a significant improvement in monitoring for enteral feeding pumps .
  • the invention uses two pressure sensors to monitor viscosity and occlusions, and to enable the enteral feeding pump to compensate for the varying amount of solution which will pass through the pump with each rotation of the rotor.
  • the pressure sensors engage the elastic tube of the infusion set and monitor changes in the strain on the infusion set by occlusions and viscosity changes .
  • the strain information can then be processed by the pump and adjustments made to the number of rotations of the pump rotor to compensate. In the event that the occlusion is too severe to compensate by modification of the rotor rotations, the pump is shut down and an alarm signal generated so that replacement tubing may be provided.
  • optical sensors One manner for decreasing the costs of pressure sensors is to use optical sensors . While there are several methods for using optical sensors to determine the presence of occlusions, each has significant drawbacks. Some methods only allow the mechanism to determine when the pressure exceeds a certain threshold. This is done by detecting when the expanding tube of the infusion set engages a surface, thereby modifying reflection or refraction of light. Other methods require complex calculations of refraction indexes or otherwise provide relatively limited information on small pressure changes.
  • some methods can vary based on the material from which the infusion set is formed, or based on whether the tube of the infusion set is opaque or transparent .
  • many mechanisms for monitoring pressure within an infusion set lack an inherent failure detector. For example, if a sensor is configured to sense only when the expanding infusion set tube engages a transparent surface, the failure to record a reflected signal may mean that the tube has not expanded. In certain situations, however, the lack of reflected signal could also mean that the sensor has failed and is either not sending the signal or is not receiving the reflected signal .
  • Such an optical pressure monitoring system should be relatively inexpensive and easy to use.
  • the optical pressure monitoring system typically includes at least one optical pressure sensor having an optical signal emitter and an optical signal receiver.
  • the optical signal emitter is intended to cover electromagnetic radiation, regardless of whether it falls within the range visible to the human eye.
  • the optical signal transmitter and the optical signal receiver are generally placed on opposing sides of the tube of the infusion set. As the tube expands and contracts due to increases or decreases in pressure, the amount of light (or radiation) received by the optical signal receiver increases or decreases at a known ratio - thereby indicating the pressure within the infusion set.
  • the tube of the infusion set is positioned between the optical signal emitter and the optical signal receiver so that it will always partially obstruct light flow between the emitter and the receiver.
  • the optical sensor ensures the infusion set has been loaded properly. If the infusion set is not properly positioned, a greater amount of light will be received by the optical signal receiver. The sensor system can then generate an alarm that the infusion set is not properly loaded in the pump .
  • the tube of the infusion set is positioned between the optical signal emitter and the optical signal receiver so that the tube will not completely occlude light from the optical signal emitter from being received by the optical signal receiver when the solution within the tube is within acceptable operating ranges.
  • the sensor system is able to conduct a continuous integrity check. If the optical signal receiver has stopped indicating receipt of light, the lack of a signal will indicate that there has been a sensor system failure and the sensor should be replaced. The failure may be either due to a faulty optical signal emitter which is not emitting the optical signal, or a faulty optical signal receiver which is not detecting the signal sent. Either way, the patient is promptly informed of the failure and can have the sensor replaced.
  • the alarm signal can be used to signal an occlusion which must be dealt with promptly. If light is still not being received once the infusion set has been removed from the sensor, the patient or technician will know that the sensor is not working and must be repaired or replaced.
  • the signals generated by the optical signal receiver indicate the extent to which the optical signal sent by the optical signal emitter have been obstructed by the tube.
  • the enteral feeding pump, etc. can convert the measured obstruction into a determination of the pressure within the enteral feeding pump, and the tubing of the infusion set expands in a known proportion to pressure increases.
  • the pressure calculations received can then be converted into information regarding the presence of occlusions and the viscosity of fluid within the infusion set. With the presence of occlusions and the viscosity of fluid within the infusion set determined, the rotations of the pump may be altered (i.e. increased or decreased) to ensure that the desired amount of solution is infused to the patient. If the pressures detected are outside of acceptable ranges, the pump can be shut down and a signal generated indicating a need to replace the infusion set.
  • a portion of the infusion set tube is made with a thin- walled portion.
  • the thin-walled portion exaggerates tube expansion and contraction due to increases and decreases in pressure.
  • the exaggerated expansions and contractions exaggerate the effect on obstruction of the light transmitted between the optical signal emitter and the optical signal receiver, thereby providing increased sensitivity to changes in the pressure within the infusion set.
  • the voltage change which is caused by the change in light obstruction can, in turn, be converted into more detailed information regarding occlusions and viscosity within the infusion set.
  • a portion of the infusion set is disposed within a jacket.
  • the jacket has an opening on one side through which the tube of the infusion set is visible.
  • the jacket On the opposing side of the tube of the infusion set, the jacket is generally solid and restricts the expansion of the tube.
  • the expansion of the tube within the jacket is exaggerated at the opening in the jacket because of the restriction caused by the rest of the jacket. This exaggerated expansion increases the sensitivity of readings obtained by the sensor, as the obstruction of light transmission between the emitter and the receiver is enhanced due to the increased movement in the tube wall .
  • the tube of the infusion set is disposed in a generally planar orientation.
  • a portion of the tube is deflected out of the planar orientation by a projection.
  • the projection is typically disposed on a side of the infusion set opposite from the portion of the wall disposed between the optical signal emitter and the optical signal receiver.
  • the projection causes an exaggeration in the expansion and/or contraction of the side of the tube of the infusion set disposed between the optical signal emitter and the optical signal receiver, thereby rendering the sensor more sensitive to pressure changes. Further enhancements in sensitivity can be obtained by controlling the configuration of the projection and the manner in which the projection engages the tube of the infusion set.
  • FIG. IA shows a side, fragmented view of a tube of an infusion set passing through an optical sensor in accordance with the principles of the present invention
  • FIG. IB shows a side view of the infusion set tube and the optical sensor of FIG. IA, wherein the infusion set tube has expanded in diameter due to increased viscosity or an occlusion within the tube
  • FIG. 1C shows a side view of the tube portion and optical sensor of FIG. IA, with the tube portion being contracted in response to decreased pressure caused by an occlusion or viscosity withing the infusion set;
  • FIG. ID shows a top view of the infusion set tube and the optical sensor of FIG. IA
  • FIG. IE shows- an end view of the optical sensor and a cross-sectional view of the infusion set tube shown in FIG. IA;
  • FIG. 2A shows a side view of a infusion set passing through an alternate embodiment of an optical sensor system in accordance with the principles of the present invention, in which a retaining jacket is used along the infusion set tube to amplify changes in tube diameter responsive to pressure changes within the tube ;
  • FIG. 2B shows a top view of the infusion set and optical sensor system of FIG. 2A
  • FIG. 2C shows a side cross-sectional view of another embodiment of the present invention which operates on principles similar to that of the embodiment shown in FIGs . 2A-2B;
  • FIG. 3 shows a side, partial cross-sectional view of yet another embodiment of the present invention in which the tube of the infusion set has a thin-walled portion;
  • FIG. 4A shows a side view of yet another embodiment of an optical sensor system made in accordance with the present invention and a portion of the tube of an infusion set passing therethrough;
  • FIG. 4B shows a bottom view of an infusion set and adapter housing in accordance with the principles of the embodiment of FIG. 4A and configured for placement in an enteral feeding pump;
  • FIG. 4C shows a cross-sectional view of FIG. 4B taken along the plane 4C-4C;
  • FIG.4D shows a cross-sectional view of a number of different abutment members configurations in accordance with the present invention.
  • FIG. 5 shows a perspective view of an enteral feeding pump employing one embodiment of an optical sensor system in accordance with the principles of the present invention.
  • FIG. 1 there is shown a fragmented side view of a tube 4 of an infusion set.
  • the tube 4 is disposed so that its lower portion 4a is positioned between an optical signal emitter 8 and an optical signal receiver 12. Together, the optical signal emitter 8 and the optical signal receiver 12 form an optical sensor, generally indicated at 16.
  • the tube 4 of the infusion set is formed from a generally elastomeric material such as silicone. However, as set forth below, other materials may be used.
  • the tube 4 is preferably positioned so that when it is in its smallest state, the lower portion 4a still partially obstruct light transmitted between the optical signal emitter 8 and the optical signal receiver 12.
  • having the lower portion 4a of the tube 4 continually obstruct light transmission' between the optical signal emitter 8 and the optical signal receiver 12 provides an important integrity check on the system by ensuring that the tube is properly loaded in the optical sensor 16.
  • the lower portion 4a of the tube can be positioned such that it is slightly occluding the light between the optical signal emitter 8 and the optical signal receiver 12 when at ambient pressure.
  • any occlusion or viscosity increase down stream from the pump mechanism(not shown) will increase pressure, causing the tube 4 to expand and move the lower portion 4a downwardly between the optical signal emitter 8 and the optical signal receiver 12.
  • the portion of the tube 4 downstream from the pump rotor will be at least as large as its ambient state.
  • a portion of the tube 4 which is positioned above the pump rotor will have a vacuum generated within the tube with each rotation (or other actuation) of the pump mechanism.
  • This vacuum is amplified by an upstream occlusion or high viscosity.
  • a portion of the tube 4 positioned upstream from the pump rotor will partially collapse or have a reduced diameter with each rotation of the pump rotor.
  • an upstream portion of the tube will need to have the lower portion 4a placed more deeply into the optical signal sensor 16 to ensure that the it continually obstructs light flow between the optical signal emitter 8 and the optical signal receiver 12.
  • the upstream portion will rarely expand beyond its ambient state.
  • a reading by the optical signal sensor 16 that there is no light obstruction can mean two things. First, it could mean that the tube 4 is not expanding beyond some predetermined threshold to cause it to enter the optical sensor. Second, it could mean that the tube 4 of the infusion set was never loaded into the pump in the first place. However, by keeping the lower portion 4a of the tube 4 of the infusion set within the optical signal sensor 16, the ambiguity of the signal can be eliminated.
  • the tube 4 has not been loaded properly. Unfortunately, it is not uncommon for health care workers and patients to be distracted while placing the infusion set into the pump. If the infusions set is not loaded properly, the solution may not be pumped to the patient, and the patient may be deprived of needed nutrients and/or medication.
  • the patient or a health care worker may have already opened a clamp on the infusion set which prevents flow prior to loading of the infusion set in the pump. If the infusion set has been inserted into the catheter in- the patient, but not properly loaded into the pump, the solution may be flowing freely under the force of gravity into the patient at a rate far in excess of that desired. For * some patients, this free-flow situation can raise serious health concerns, as the patient's body may not be able to handle the sudden "flood" of solution. This is especially true if the solution is medicated.
  • the tube -4 properly positioned with the optical signal sensor 16 both the patient and the health care worker can be assured that the flow of solution is being controlled by the enteral feeding pump.
  • the tube 4 In addition to always keeping the lower portion 4a of the tube 4 at least partially within the optical signal sensor 16, it is also desirable that the tube not be positioned so that it will completely obstruct light transmission between the optical signal emitter 8 and the optical signal receiver 12 during normal operation.
  • an integrity check on the optical signal sensor is made each time a reading is processed. If some light is being received by the optical signal receiver 12 , then the sensor 16 must be working. If no light is being received, the optical signal sensor 16 has malfunctioned and an alarm is generated.
  • a virtual total obstruction of light transmission between the optical signal emitter 8 and the optical signal receiver 12 could also be used to determine when the infusion set has an occlusion or excessive viscosity.
  • an ambiguous alarm is created which could mean excessive pressure or a faulty sensor.
  • the pump if the pump detects an occlusion, an improper loading of the tube 4 of the infusion set, or a faulty optical signal sensor 16, the pump will generate one or more alarms and provide notice of the problem. The patient or health care worker may then correct the problem and restore the solution flow to the desired level.
  • IB there is shown a side view of the infusion set tube 4 positioned between the optical signal emitter 8 and the optical signal receiver 12.
  • the optical signal emitter 8 and the optical signal receiver 12 are positioned immediately adjacent to the tube 4.
  • both upstream and downstream portions of the tube 4 will be disposed in optical signal sensors 16 positioned near the pump mechanism to monitor pressure changes due to occlusions and viscosity.
  • the pump will be able to detect both upstream and downstream occlusions and changes in viscosity which may interfere with delivery of the predetermined amount of solution.
  • FIG. IB shows a tube 4' which has increased in diameter due to an occlusion downstream from the sensor.
  • the pump can be shut down until it has been checked.
  • FIG. 1C shows an upstream portion of the tube 4' ' positioned between an optical signal emitter 8a and an optical signal receiver 12a. Unlike the downstream portion of the tube 4 ' , the upstream portion of the tube 4 ' ' will generally have a vacuum created therein with each rotation of the pump rotor (or other actuating movement of the pump mechanism) . Thus, the tube 4'' in FIG. 1C is smaller in diameter than the tube 4 in FIG. IA and much smaller in diameter than the tube 4 ' in FIG. IB.
  • the pump can increase the number or frequency of rotations (or other actuating motion) to compensate for the pressure changes, and thereby ensure that the proper amount of solution is being delivered to the patient. If the occlusion or viscosity is causing too much impediment to solution flow through the tube 4 ' ' , the pump can generate an alarm, thereby informing the user or health care worker that the infusion set must be checked.
  • the upstream optical signal sensor 16a can fail.
  • the tube 4'' of the infusion set can be loaded improperly.
  • FIG. ID there is shown a top view of the infusion set tube 4 and the optical signal sensor 16 of FIG. IA.
  • the optical signal emitter 8 and the optical signal receiver 12 are positioned immediately adjacent the tube 4 of the infusion set. While the optical signal emitter 8 and the optical signal receiver 12 need not touch the tube 4, having the two sensors constrict radial expansion on the sides of the tube will cause increased expansion of the tube vertically, thereby amplifying the changes caused by pressure.
  • FIG. IE shows a cross-sectional view of the tube 4 and an end view of the optical signal emitter 8 and the optical signal receiver 12. From this view, it is apparent that radial expansion of the tube 4 will interfere with transmission of optical signals, represented by arrows 18, between the optical signal emitter 8 and the optical signal receiver 12.
  • the extent to which the tube 4 interferes with the light transmission is proportional to the pressure changes which occur within the tube during operation of the pump. It is not proportional to, the reflective index of the material or whether the material is clear or opaque. Thus, a variety of materials could be used for the tube 4 if desired.
  • FIG. 2A shows a side view of a infusion set 24 passing through an alternate embodiment of an optical sensor system 36 in accordance with the principles of the present invention.
  • a jacket 40 Disposed along the tube 24 of the infusion set is a jacket 40. While the tube 24 of the infusion set is formed from a radially expandable material such as silicone, the jacket 40 is formed from a generally rigid material that will have minimal if any radial expansion in the pressure range typically associated with solution feeding systems.
  • the window 44 In the top of the jacket 40 is an window 44.
  • the window 44 exposes a portion 24a of the tube 24 of the infusion set. Because the jacket 40 constricts expansion of the tube 24, expansion created by changes in the tube are amplified in the portion 24a of the tube adjacent the window.
  • the optical signal emitter 28 and the optical signal receiver 32 disposed on opposing sides of the window 44, the pressure changes within the infusion set can be more accurately determined due to the amplification created by the jacket 40.
  • FIG. 2B there is shown a top view of the infusion set, including the tube 24 and the jacket 40.
  • the optical signal emitter 28 and the optical signal receiver 32 of the optical signal sensor 36 are disposed on opposing sides of the window 44 in the jacket so as to monitor the rise and fall of the portion 24a of the tube 24 exposed by the window 44.
  • FIG. 2C shows a cross-sectional view of an alternate embodiment of the present invention, which operates in substantially the same manner as the embodiment shown in FIGs . 2A and 2B.
  • the infusion set generally indicated at 50, has a rigid tube 52 and a radially expandable tube 54.
  • the rigid tube 52 has an opening or window 56 which is covered by a portion 54a of the radially expandable tube 54.
  • the portion 54a tends to expand to a greater degree than the remainder of the tube 54 because the rigid tube 52 constricts expansion in all but one direction.
  • placing the optical signal sensor (not shown in FIG. 2C) adjacent the portion 54a of the tube 54 provides improved sensitivity.
  • the infusion set 60 includes a tube 64 disposed between the optical signal emitter (shown in shadow 68) and the optical signal receiver (shown in shadow 72) of the optical signal sensor 76.
  • the portion 64a of the tube 64 disposed between the optical signal sensor 76 has a thin-walled portion on one side.
  • the thin-wall portion is between 0.025 and 0.050.
  • the outer circumference of the tube 64 and will be between 0.175 and 0.300 thinner than the normal thickness of the tube 64. As pressure within the tube 64 changes, the thin-walled portion 64a will expand and contract to a greater extent.
  • FIG. 4A there is shown a side view of yet another embodiment of an optical sensor system made in accordance with the present invention and a portion of the tube of an infusion set passing therethrough.
  • the tube 84 is disposed generally above an optical signal emitter 88 and an optical signal receiver 92 which form an optical signal sensor, generally indicated at 96.
  • the tube 84 is positioned in a generally planar configuration. However, a portion 84a of the tube 84 positioned above the space between the optical signal emitter 88 and the optical signal receiver 92 is engaged by an abutment member 100 so as to deflect that portion of the tube into the space 104 between the optical signal emitter 88 and the optical signal receiver 92.
  • the abutment member 100 serves two valuable functions. First, the abutment member 100 helps to ensure the tube 84 of the infusion set is in the desired location and helps resist movement of the tube which may be caused by the pump mechanism. Second, the abutment member 100 prevents expansion of the tube 84 along the top side thereof adjacent to the optical signal sensor 96. This causes pressure changes to expand and contract the opposing wall 84b of the tube in an exaggerated manner to how the sidewalls of the tube will normally respond to pressure changes. As with the embodiments discussed above, this exaggerated movement allows the optical signal sensor 96 to detect smaller changes in pressure, and thereby provide more accuracy in determining pressure changes within the infusion set. Turning now to FIG.
  • the infusion set includes an upstream intake tube 86a and a downstream output tube 86b.
  • the tube 84 of the infusion set has a looped portion 84c which wraps around the rotor (not shown) of an enteral feeding pump, or similar device.
  • the abutment member 100 is disposed to engage the tube 84 of the infusion set 86 both upstream and downstream from the pump rotor.
  • pressure is monitored both upstream and downstream from the pump rotor to ensure that 1) a known quantity of solution reaches the portion of the tube 84 which engages the pump rotor, and 2) that the solution pumped by the pump rotor reaches the patient.
  • the tube 84 of the infusion set 86 is typically made from an elastomeric material such as silicone. This allows the tube 84 to stretch and to expand and contract is it is worked by the pump rotor to move solution through the tube.
  • the remainder of the infusion set 86 need not be formed from silicone. To the contrary, less expensive tubing can be used for the remainder of the infusion set 86.
  • the silicone tube 84 and the remainder of the infusion set 86 are typically held together by an adaptor 108 having two connectors 110. These connectors 110 can be formed as an integral, one piece adaptor including the abutment member 100, or can be formed separately. As the pump rotor rotates, a vacuum is created in the upstream portion 84d of the tube 84 of the infusion set.
  • This vacuum will cause tube portion 84b along the upstream portion 84d to contract.
  • the extent of contraction and the time necessary to return to ambient is a function of the viscosity of the solution upstream from the pump rotor and the presence of any occlusions.
  • the enteral feeding pump is able to determine the viscosity and occlusion's effect on solution flow rate and thereby determine the amount of solution which is being pumped by each rotation of the pump rotor. This is typically done by monitoring the voltage produced by the optical signal receiver. The greater the voltage which is received, the greater the amount of light which is getting passed the tube portion 84b.
  • the voltage reading will be higher than expected and the enteral feeding pump can generate an alarm signal indicating that a predetermined threshold has been passed.
  • the downstream portion 84e will receive increased pressure with each rotation of the pump rotor, thereby causing the downstream portion 84b to expand. The expansion will restrict light flow from the optical signal emitter to the optical signal receiver, thereby decreasing the voltage generated.
  • the optical signal sensor (not shown) will produce voltage readings indicative of the excess or prolonged expansion of portion 84b along the downstream portion 84e of the tube 84.
  • the enteral feeding pump can then generate an alarm indicating an occlusion downstream. This will prevent the patient from being subject to sudden pressure increases which could cause discomfort or even injury.
  • the abutment member 100 increases the accuracy of the optical signal sensor 96 by exaggerating the expansion (downstream) or contraction (upstream) along the tube portion 84b. This exaggerated movement enables the enteral feeding pump to more accurately determine pressure by the voltage readings produced by the optical signal sensor.
  • FIG. 4C there is shown a cross- sectional view of the tube 84 of the infusion set 86, and fragmented views of the abutment members 100a and 100b.
  • the monitored property is almost always contraction of the tube.
  • the end of the projection should have a thickness (i.e. a cross-section taken generally co- planar with the cross-section of the tube) with a radius which is 1/8 the diameter of the tube 84.
  • the narrow projection formed by the abutment member 84a allows the outer edges of the tube 84 to move upward and downwardly. This has been found to increase sensitivity to the vacuum created within the upstream portion 84d of the tube 84, and thereby enables the voltage reading of the associated optical signal sensor to more accurately indicate the pressure within the tube .
  • downstream portion 84e of the tube 84 generally monitors only pressures at ambient or greater, it is not necessary for the abutment member
  • the abutment member 100b is generally broader and generally presses against the entire top of the tube 84 at the location adjacent the optical signal sensor. As the pressure in the downstream portion 84e of the tube 84 increases, the relatively flat abutment member 100b limits expansion of the tube upwardly, thereby causing exaggerated expansion on the opposing side 84b of the tube 84. While a relatively narrow protrusion 100a and a broad protrusion 100b are shown for the abutment members, those skilled in the art will appreciate that abutment members having a variety of cross-sections may be used. For example, FIG. 4D shows the cross- section of protrusions which are generally squared, semi-oval and triangular. Through routine experimentation, those skilled in the art will be able to determine appropriate voltage curves associated with the shape and the tubing to be used.
  • FIG. 5 there is shown a perspective view of an enteral feeding pump, generally indicated at 130, formed in accordance with the principles of the present invention.
  • the pump 130 includes a motor unit 134 with a digital readout 138 and a plurality of control buttons 142.
  • the motor unit 134 controls a rotor 146, which has a plurality of rollers 150 (typically three) which are configured to engage the tube 84 of the infusion set 86. As the rotor 146 rotates, the rollers 150 selectively pinch off the tube 84 and push solution contained therein downstream. If no pressure changes where present, one could readily determine the amount of solution moved by the pump 130 by simply counting the rotations .
  • the pressures within the infusion set 86 effect the amount of solution which is moved by each rotation of the rotor 146. By determining these pressures, one can quite accurately calculate the amount of fluid being pumped. Thus, it is important to track the upstream and downstream pressures in the infusion set 86.
  • the connectors 110' which connect the intake tube 86a and output tube 86b of the infusion set 86 to the tube 84 are formed integrally with an anti-free flow device 160 which is disposed within the tube 84 in the form of an adaptor housing 164 which nests within a pair of channels 168 on the enteral feeding pump 130.
  • the housing may also have integrally formed therein one or more abutment members similar to those discussed above.
  • a cover 170 which is used to hold the housing 164 to the channels 168 of the enteral feeding pump 130 may have one or more abutment members 174 formed thereon. Closing the cover 170 causes the abutment member 174 to extend through an opening in the housing 164 and to engage the tube 84.
  • the tube 84 is then automatically and properly positioned between the optical signal emitter and the optical signal receiver (not visible in FIG. 5) which are disposed along the channels 168.
  • a catch 178 can be used to hold the cover 170 closed.
  • the enteral feeding pump 130 can readily determine and display the amount of solution which is being pumped during a given amount of time. It can also develop a signal when thresholds are exceeded, and can indicate trends in increased or decreased viscosity if desired. Furthermore, if the pump has been set to deliver a predetermined amount of solution in a given time, the enteral feeding pump 130 is able to adjust the rotor frequency (i.e. the number of times the rotor 146 rotates in a given amount of time) to ensure the desired amount of solution has been delivered. Thus, the present invention is able to obtain the advantages set forth in U.S.
  • Patent No .5 , 720, 721 without the need of using pressure transducers or other similar, costly devices.
  • an optical sensor can be used to provide highly accurate pressure and viscosity information while substantially lowering the cost of the enteral feeding pump.

Abstract

An optical pressure monitoring system includes a tube (4) from which an infusion set and an optical signal sensor (16) disposed to detect changes in the diameter of the tube (4) and thereby determine pressure changes within the tube (4).

Description

OPTICAL PRESSURE MONITORING SYSTEM
BACKGROUND OF THE INVENTION
1. Field of the Invention.
The present invention relates to systems for feeding solutions to patients. More particularly, the present invention relates to a system and method for monitoring fluid pressures to ensure that the solution is properly fed to the patient by the enteral feeding pump or similar device. Specifically, the invention relates to the use of optical pressure sensors to monitor fluid pressures and the presence of occlusions in the delivery set which may interfere with solution flow to the patient, and so that operation of the enteral feeding pump may be modified to compensate for the pressure and/or occlusion and thereby provide highly accurate solution delivery.
2. State of the Art.
There are numerous situations in which a solution must be fed to a patient over a period of time. In some situations, the solution is provided directly into the blood stream of the patient. Saline solutions and medications supplied in such a manner are typically referred to as parenteral solutions. Because parenteral solutions are often necessary to hydrate the patient, or supply needed medications, occlusion of the infusion delivery set can be particularly dangerous to the patient. Thus, it is important to ensure that occlusions are not impeding solution flow. However, parenteral solutions typically have a very low viscosity in order to faciliate absorption into the blood stream. Therefore, the risk of occlusion of the infusion set is relatively small so long as the tube is not pinched shut by folding or some other external application of force.
In contrast to a parenteral system, an enteral feeding system is used to provide nutrient solutions to patients who, for one reason or an other, are unable to eat for themselves . Such a system typically includes a pump which is attached to an input tube connected to a supply container and to an output tube which is connected to a patient. The pump draws nutrient solution from the supply container and delivers the solution to the patient. By adjusting the number of rotations of the motor, or the frequency of rotations, in the pump, an enteral feeding pump can adjust its output to deliver a predetermined amount of nutrient solution (or even medication) at a desired rate. A significant problem with currently available enteral feeding systems, is that the intake and output tubes may become occluded. Unlike parenteral solutions, enteral feeding solutions have a relatively high viscosity, as they must carry sufficient nutrition to sustain the patient. Occlusion can occur, for example, if a fibrous substance is included in the enteral feeding solution and somehow combines to interfere with flow through the tube. Occlusion can also occur if a tube is bent sufficiently to interfere with flow therethrough, or if a roller clamp (as is commonly used for intravenous applications) is not sufficiently opened. Because of the viscosity of the solution, the amount of kinking of the tube or other interference required to interfere with solution flow is significantly less than that required in a parenteral infusion set . If the intake tube becomes occluded, insufficient solution may be supplied to the pump, and thus to the patient. If the output tube becomes occluded, the flow of solution may be blocked, or the solution may be suddenly delivered at unusually high pressures. Additionally, medical personnel may fail to notice that the supply container is out of solution, or may not properly mount the intake and/or output tubes in the pump, thereby preventing the proper amount of solution from being delivered to the patient. Any of these scenarios can have tragic consequences if allowed to continue for a prolonged period of time.
Yet another concern with enteral feeding systems is that of viscosity of the solution and viscosity changes as a container full of solution is pumped to a patient. Knowing the viscosity of the fluid being pumped through the enteral feeding system is important because different viscosities are pumped at different rates by the enteral feeding pump. For example, a lower quantity of a highly viscous solution will be pumped by a given number of rotations of the enteral feeding pump motor than will be moved by the same pump when the solution has low viscosity. In other words, the amount of solution fed to the patient can differ substantially depending on the solution's viscosity. Thus, unless the pump is able to accurately determine and compensate for viscosity changes in the solution (i.e. by increasing or decreasing the rotations of the pump rotor in a given period of time) , it is difficult to know exactly how much of the solution has been fed to the patient.
To overcome these concerns, there is a need for a system and method for determining flow discrepancies due to occlusions, viscosity (including changing viscosity) and/or improper fitting of pumps and intake/output tubes so that patients will not be endangered, and so that the proper amount of fluid will be delivered to the patient.
U.S. Patent No. 5,720,721 (February 24, 1998), which is expressly incorporated herein, provides a significant improvement in monitoring for enteral feeding pumps . The invention uses two pressure sensors to monitor viscosity and occlusions, and to enable the enteral feeding pump to compensate for the varying amount of solution which will pass through the pump with each rotation of the rotor. The pressure sensors engage the elastic tube of the infusion set and monitor changes in the strain on the infusion set by occlusions and viscosity changes . The strain information can then be processed by the pump and adjustments made to the number of rotations of the pump rotor to compensate. In the event that the occlusion is too severe to compensate by modification of the rotor rotations, the pump is shut down and an alarm signal generated so that replacement tubing may be provided.
While the pressure sensor system of U.S. Patent No.5, 720, 721 is a significant improvement over the art, it does have limitations. The pressure sensors described in the λ 721 patent are relatively expensive and must be properly mounted in the pump. Additionally, the person loading the pump must make sure that the upstream and downstream portions of the infusion set are properly loaded in the pump housing so that they engage the pressure sensors in the proper manner. Failure to properly load the infusion set can interfere with the functioning of the pressure sensors.
One manner for decreasing the costs of pressure sensors is to use optical sensors . While there are several methods for using optical sensors to determine the presence of occlusions, each has significant drawbacks. Some methods only allow the mechanism to determine when the pressure exceeds a certain threshold. This is done by detecting when the expanding tube of the infusion set engages a surface, thereby modifying reflection or refraction of light. Other methods require complex calculations of refraction indexes or otherwise provide relatively limited information on small pressure changes.
Additionally, some methods can vary based on the material from which the infusion set is formed, or based on whether the tube of the infusion set is opaque or transparent . In addition to the above, many mechanisms for monitoring pressure within an infusion set lack an inherent failure detector. For example, if a sensor is configured to sense only when the expanding infusion set tube engages a transparent surface, the failure to record a reflected signal may mean that the tube has not expanded. In certain situations, however, the lack of reflected signal could also mean that the sensor has failed and is either not sending the signal or is not receiving the reflected signal . Thus, there is a need for an improved optical pressure monitoring system and method of use. Such an optical pressure monitoring system should be relatively inexpensive and easy to use. It should also provide highly accurate determination of pressure changes which indicate occlusions and/or viscosity changes. Furthermore, it should enable the use of infusion sets made from a variety of materials and without regard to whether the infusion set is formed of a tube which is transparent or opaque. SUMMARY OF THE INVENTION
Thus, it is an object of the present invention to provide an improved method for monitoring viscosity and/or occlusions in an infusion set. It is another object of the present invention to provide such a method which monitors viscosity and occlusions with an optical sensor system.
It is another object of the present invention to provide such a method in which the material used to form the infusion set does not interfere with proper pressure monitoring.
It is yet another object of the present invention to provide such a method in which the transparency or opaqueness of the solution does not interfere with proper pressure monitoring.
It is still another object of the present invention to provide an optical pressure sensor system with enhanced sensitivity.
It is still another object of the present invention to provide such a sensor system which checks the integrity of the sensor and which ensures that the infusion set is properly loaded in the sensor system.
The various objects set forth above and other objects of the invention are realized in specific illustrated embodiments of a optical pressure monitoring sensor system for monitoring occlusions and viscosity. It will be appreciated that all embodiments set forth may not accomplish all objects of the invention, but that preferred embodiments will accomplish a number of the objects and thereby provide an improvement over the prior art discussed above.
The optical pressure monitoring system typically includes at least one optical pressure sensor having an optical signal emitter and an optical signal receiver. (As used herein, it should be understood that the optical signal emitter is intended to cover electromagnetic radiation, regardless of whether it falls within the range visible to the human eye.) The optical signal transmitter and the optical signal receiver are generally placed on opposing sides of the tube of the infusion set. As the tube expands and contracts due to increases or decreases in pressure, the amount of light (or radiation) received by the optical signal receiver increases or decreases at a known ratio - thereby indicating the pressure within the infusion set. In accordance with another aspect of the present invention, the tube of the infusion set is positioned between the optical signal emitter and the optical signal receiver so that it will always partially obstruct light flow between the emitter and the receiver. In such a configuration, the optical sensor ensures the infusion set has been loaded properly. If the infusion set is not properly positioned, a greater amount of light will be received by the optical signal receiver. The sensor system can then generate an alarm that the infusion set is not properly loaded in the pump .
In accordance with another aspect of the present invention, the tube of the infusion set is positioned between the optical signal emitter and the optical signal receiver so that the tube will not completely occlude light from the optical signal emitter from being received by the optical signal receiver when the solution within the tube is within acceptable operating ranges. In such a configuration, the sensor system is able to conduct a continuous integrity check. If the optical signal receiver has stopped indicating receipt of light, the lack of a signal will indicate that there has been a sensor system failure and the sensor should be replaced. The failure may be either due to a faulty optical signal emitter which is not emitting the optical signal, or a faulty optical signal receiver which is not detecting the signal sent. Either way, the patient is promptly informed of the failure and can have the sensor replaced.
In the alternative, if the infusion set is positioned to allow complete occlusion of light when the pressure in the infusion set exceeds an acceptable threshold, the alarm signal can be used to signal an occlusion which must be dealt with promptly. If light is still not being received once the infusion set has been removed from the sensor, the patient or technician will know that the sensor is not working and must be repaired or replaced.
Between the two extremes of receiving a full optical signal and no optical signal, the signals generated by the optical signal receiver indicate the extent to which the optical signal sent by the optical signal emitter have been obstructed by the tube. The enteral feeding pump, etc., can convert the measured obstruction into a determination of the pressure within the enteral feeding pump, and the tubing of the infusion set expands in a known proportion to pressure increases. The pressure calculations received can then be converted into information regarding the presence of occlusions and the viscosity of fluid within the infusion set. With the presence of occlusions and the viscosity of fluid within the infusion set determined, the rotations of the pump may be altered (i.e. increased or decreased) to ensure that the desired amount of solution is infused to the patient. If the pressures detected are outside of acceptable ranges, the pump can be shut down and a signal generated indicating a need to replace the infusion set.
While the monitoring of the tube diameter described above provides improvements over the prior art, it has been found that yet additional improvements in sensitivity can be achieved. In accordance with one aspect of the present invention, a portion of the infusion set tube is made with a thin- walled portion. The thin-walled portion exaggerates tube expansion and contraction due to increases and decreases in pressure. The exaggerated expansions and contractions exaggerate the effect on obstruction of the light transmitted between the optical signal emitter and the optical signal receiver, thereby providing increased sensitivity to changes in the pressure within the infusion set. The voltage change which is caused by the change in light obstruction can, in turn, be converted into more detailed information regarding occlusions and viscosity within the infusion set.
In accordance with another aspect of the invention, a portion of the infusion set is disposed within a jacket. The jacket has an opening on one side through which the tube of the infusion set is visible. On the opposing side of the tube of the infusion set, the jacket is generally solid and restricts the expansion of the tube. As the pressure in the infusion set increases, the expansion of the tube within the jacket is exaggerated at the opening in the jacket because of the restriction caused by the rest of the jacket. This exaggerated expansion increases the sensitivity of readings obtained by the sensor, as the obstruction of light transmission between the emitter and the receiver is enhanced due to the increased movement in the tube wall .
In accordance with another aspect of the present invention the tube of the infusion set is disposed in a generally planar orientation. A portion of the tube is deflected out of the planar orientation by a projection. The projection is typically disposed on a side of the infusion set opposite from the portion of the wall disposed between the optical signal emitter and the optical signal receiver. The projection causes an exaggeration in the expansion and/or contraction of the side of the tube of the infusion set disposed between the optical signal emitter and the optical signal receiver, thereby rendering the sensor more sensitive to pressure changes. Further enhancements in sensitivity can be obtained by controlling the configuration of the projection and the manner in which the projection engages the tube of the infusion set.
BRIEF DESCRIPTION OF THE DRAWINGS
The above and other objects, features and advantages of the invention will become apparent from a consideration of the following detailed description presented in connection with the accompanying drawings in which:
FIG. IA shows a side, fragmented view of a tube of an infusion set passing through an optical sensor in accordance with the principles of the present invention; FIG. IB shows a side view of the infusion set tube and the optical sensor of FIG. IA, wherein the infusion set tube has expanded in diameter due to increased viscosity or an occlusion within the tube; FIG. 1C shows a side view of the tube portion and optical sensor of FIG. IA, with the tube portion being contracted in response to decreased pressure caused by an occlusion or viscosity withing the infusion set;
FIG. ID shows a top view of the infusion set tube and the optical sensor of FIG. IA; FIG. IE shows- an end view of the optical sensor and a cross-sectional view of the infusion set tube shown in FIG. IA;
FIG. 2A shows a side view of a infusion set passing through an alternate embodiment of an optical sensor system in accordance with the principles of the present invention, in which a retaining jacket is used along the infusion set tube to amplify changes in tube diameter responsive to pressure changes within the tube ;
FIG. 2B shows a top view of the infusion set and optical sensor system of FIG. 2A; FIG. 2C shows a side cross-sectional view of another embodiment of the present invention which operates on principles similar to that of the embodiment shown in FIGs . 2A-2B;
FIG. 3 shows a side, partial cross-sectional view of yet another embodiment of the present invention in which the tube of the infusion set has a thin-walled portion;
FIG. 4A shows a side view of yet another embodiment of an optical sensor system made in accordance with the present invention and a portion of the tube of an infusion set passing therethrough;
FIG. 4B shows a bottom view of an infusion set and adapter housing in accordance with the principles of the embodiment of FIG. 4A and configured for placement in an enteral feeding pump;
FIG. 4C shows a cross-sectional view of FIG. 4B taken along the plane 4C-4C; and
FIG.4D shows a cross-sectional view of a number of different abutment members configurations in accordance with the present invention; and
FIG. 5 shows a perspective view of an enteral feeding pump employing one embodiment of an optical sensor system in accordance with the principles of the present invention. DETAILED DESCRIPTION
Reference will now be made to the drawings in which the various elements of the present invention will be given numeral designations and in which the invention will be discussed so as to enable one skilled in the art to make and use the invention. It is to be understood that the following description is only exemplary of the principles of the present invention, and should not be viewed as narrowing the pending claims.
Referring to FIG. 1, there is shown a fragmented side view of a tube 4 of an infusion set. The tube 4 is disposed so that its lower portion 4a is positioned between an optical signal emitter 8 and an optical signal receiver 12. Together, the optical signal emitter 8 and the optical signal receiver 12 form an optical sensor, generally indicated at 16. The tube 4 of the infusion set is formed from a generally elastomeric material such as silicone. However, as set forth below, other materials may be used.
The tube 4 is preferably positioned so that when it is in its smallest state, the lower portion 4a still partially obstruct light transmitted between the optical signal emitter 8 and the optical signal receiver 12. As will be discussed in detail below, having the lower portion 4a of the tube 4 continually obstruct light transmission' between the optical signal emitter 8 and the optical signal receiver 12 provides an important integrity check on the system by ensuring that the tube is properly loaded in the optical sensor 16. For a tube 4 of an infusion set which is positioned down stream of the pumping mechanism, the lower portion 4a of the tube can be positioned such that it is slightly occluding the light between the optical signal emitter 8 and the optical signal receiver 12 when at ambient pressure. This is because any occlusion or viscosity increase down stream from the pump mechanism(not shown) will increase pressure, causing the tube 4 to expand and move the lower portion 4a downwardly between the optical signal emitter 8 and the optical signal receiver 12. In virtually all scenarios, the portion of the tube 4 downstream from the pump rotor will be at least as large as its ambient state.
In contrast, a portion of the tube 4 which is positioned above the pump rotor will have a vacuum generated within the tube with each rotation (or other actuation) of the pump mechanism. This vacuum is amplified by an upstream occlusion or high viscosity. Thus, a portion of the tube 4 positioned upstream from the pump rotor will partially collapse or have a reduced diameter with each rotation of the pump rotor. Thus, to keep the tube 4 in a position in which it will partially obstruct light between the optical signal emitter 8 and the optical signal receiver 12, an upstream portion of the tube will need to have the lower portion 4a placed more deeply into the optical signal sensor 16 to ensure that the it continually obstructs light flow between the optical signal emitter 8 and the optical signal receiver 12. Of course, because occlusions are manifest by a vacuum within the upstream portion of the tube 4, the upstream portion will rarely expand beyond its ambient state.
Positioning the tube 4 so that it is always at least partially between the optical signal transmitter 8 and the optical signal receiver 12 provides an important integrity check for the system. If the lower portion 4a of the tube 4 is not initially positioned to partially obstruct light, a reading by the optical signal sensor 16 that there is no light obstruction can mean two things. First, it could mean that the tube 4 is not expanding beyond some predetermined threshold to cause it to enter the optical sensor. Second, it could mean that the tube 4 of the infusion set was never loaded into the pump in the first place. However, by keeping the lower portion 4a of the tube 4 of the infusion set within the optical signal sensor 16, the ambiguity of the signal can be eliminated. If the optical signal receiver 12 detects no obstruction of light between the optical signal emitter 8 and the optical signal receiver 12, the tube 4 has not been loaded properly. Unfortunately, it is not uncommon for health care workers and patients to be distracted while placing the infusion set into the pump. If the infusions set is not loaded properly, the solution may not be pumped to the patient, and the patient may be deprived of needed nutrients and/or medication.
In the alternative, the patient or a health care worker may have already opened a clamp on the infusion set which prevents flow prior to loading of the infusion set in the pump. If the infusion set has been inserted into the catheter in- the patient, but not properly loaded into the pump, the solution may be flowing freely under the force of gravity into the patient at a rate far in excess of that desired. For* some patients, this free-flow situation can raise serious health concerns, as the patient's body may not be able to handle the sudden "flood" of solution. This is especially true if the solution is medicated. By having the tube -4 properly positioned with the optical signal sensor 16, both the patient and the health care worker can be assured that the flow of solution is being controlled by the enteral feeding pump.
In addition to always keeping the lower portion 4a of the tube 4 at least partially within the optical signal sensor 16, it is also desirable that the tube not be positioned so that it will completely obstruct light transmission between the optical signal emitter 8 and the optical signal receiver 12 during normal operation. By having the tube 4 positioned to always allow some light flow between the optical signal emitter 8 and the optical signal receiver 12, an integrity check on the optical signal sensor is made each time a reading is processed. If some light is being received by the optical signal receiver 12 , then the sensor 16 must be working. If no light is being received, the optical signal sensor 16 has malfunctioned and an alarm is generated.
Those skilled in the art will appreciate that a virtual total obstruction of light transmission between the optical signal emitter 8 and the optical signal receiver 12 could also be used to determine when the infusion set has an occlusion or excessive viscosity. However, in such a scenario, an ambiguous alarm is created which could mean excessive pressure or a faulty sensor. In any event, if the pump detects an occlusion, an improper loading of the tube 4 of the infusion set, or a faulty optical signal sensor 16, the pump will generate one or more alarms and provide notice of the problem. The patient or health care worker may then correct the problem and restore the solution flow to the desired level. Turning now to FIG. IB, there is shown a side view of the infusion set tube 4 positioned between the optical signal emitter 8 and the optical signal receiver 12. Typically, the optical signal emitter 8 and the optical signal receiver 12 are positioned immediately adjacent to the tube 4. Preferably, both upstream and downstream portions of the tube 4 will be disposed in optical signal sensors 16 positioned near the pump mechanism to monitor pressure changes due to occlusions and viscosity. Thus, the pump will be able to detect both upstream and downstream occlusions and changes in viscosity which may interfere with delivery of the predetermined amount of solution.
As shown in FIG. IB, the optical sensor 16 is positioned on a downstream portion of the tube 4. With each rotation of the pump rotor, solution is forced down the tube 4, causing a short pressure increase and expansion of the tube. If the viscosity of the solution changes significantly or there is an occlusion, the amount of pressure increase and/or its duration will change. FIG. IB shows a tube 4' which has increased in diameter due to an occlusion downstream from the sensor. By monitoring- the extent of the increase in tube size, the effect of any occlusions can be determined. While some partial occlusions may effect flow relatively little, an occlusion can also significantly impair solution flow and can cause the solution to be delivered to the patient at an undesirably high pressure. Thus, if the optical sensor 16 detects a pressure increase above a predetermined threshold, an alarm will be generated indicating that the infusion set should be checked.
If the pressure detected by the optical signal sensor 16 is so high as to present safety concerns, the pump can be shut down until it has been checked.
FIG. 1C shows an upstream portion of the tube 4' ' positioned between an optical signal emitter 8a and an optical signal receiver 12a. Unlike the downstream portion of the tube 4 ' , the upstream portion of the tube 4 ' ' will generally have a vacuum created therein with each rotation of the pump rotor (or other actuating movement of the pump mechanism) . Thus, the tube 4'' in FIG. 1C is smaller in diameter than the tube 4 in FIG. IA and much smaller in diameter than the tube 4 ' in FIG. IB.
While each rotation of the rotor will cause the tube 4'' to temporarily shrink in diameter, the presence of occlusions or high viscosity can amplify the shrinking and require additional time for the tube to return to its normal diameter. If the tube has not returned to its normal diameter by the time the pump conducts its next rotation, there will be less solution in the tube for movement by the tube, and each rotation of the pump rotor will deliver less solution than when the solution is at normal pressure.
By monitoring the upstream pressure in the infusion set, however, the pump can increase the number or frequency of rotations (or other actuating motion) to compensate for the pressure changes, and thereby ensure that the proper amount of solution is being delivered to the patient. If the occlusion or viscosity is causing too much impediment to solution flow through the tube 4 ' ' , the pump can generate an alarm, thereby informing the user or health care worker that the infusion set must be checked.
As with the downstream optical signal sensor 16, the upstream optical signal sensor 16a can fail. Likewise, the tube 4'' of the infusion set can be loaded improperly. Thus, it is preferred to have the tube 4'' always obstruct some, but not all, of the light flow between the optical signal emitter 8a and the optical signal receiver 12a.
Turning now to FIG. ID, there is shown a top view of the infusion set tube 4 and the optical signal sensor 16 of FIG. IA. In such an embodiment it is preferred that the optical signal emitter 8 and the optical signal receiver 12 are positioned immediately adjacent the tube 4 of the infusion set. While the optical signal emitter 8 and the optical signal receiver 12 need not touch the tube 4, having the two sensors constrict radial expansion on the sides of the tube will cause increased expansion of the tube vertically, thereby amplifying the changes caused by pressure.
FIG. IE shows a cross-sectional view of the tube 4 and an end view of the optical signal emitter 8 and the optical signal receiver 12. From this view, it is apparent that radial expansion of the tube 4 will interfere with transmission of optical signals, represented by arrows 18, between the optical signal emitter 8 and the optical signal receiver 12. The extent to which the tube 4 interferes with the light transmission is proportional to the pressure changes which occur within the tube during operation of the pump. It is not proportional to, the reflective index of the material or whether the material is clear or opaque. Thus, a variety of materials could be used for the tube 4 if desired.
FIG. 2A shows a side view of a infusion set 24 passing through an alternate embodiment of an optical sensor system 36 in accordance with the principles of the present invention. Disposed along the tube 24 of the infusion set is a jacket 40. While the tube 24 of the infusion set is formed from a radially expandable material such as silicone, the jacket 40 is formed from a generally rigid material that will have minimal if any radial expansion in the pressure range typically associated with solution feeding systems.
In the top of the jacket 40 is an window 44. The window 44 exposes a portion 24a of the tube 24 of the infusion set. Because the jacket 40 constricts expansion of the tube 24, expansion created by changes in the tube are amplified in the portion 24a of the tube adjacent the window. By having the optical signal emitter 28 and the optical signal receiver 32 disposed on opposing sides of the window 44, the pressure changes within the infusion set can be more accurately determined due to the amplification created by the jacket 40.
Turning now to FIG. 2B, there is shown a top view of the infusion set, including the tube 24 and the jacket 40. The optical signal emitter 28 and the optical signal receiver 32 of the optical signal sensor 36 are disposed on opposing sides of the window 44 in the jacket so as to monitor the rise and fall of the portion 24a of the tube 24 exposed by the window 44. FIG. 2C shows a cross-sectional view of an alternate embodiment of the present invention, which operates in substantially the same manner as the embodiment shown in FIGs . 2A and 2B. Instead of having a jacket, however, the infusion set, generally indicated at 50, has a rigid tube 52 and a radially expandable tube 54. The rigid tube 52 has an opening or window 56 which is covered by a portion 54a of the radially expandable tube 54. As with the portion 24a in FIGs. 2A and 2B, the portion 54a tends to expand to a greater degree than the remainder of the tube 54 because the rigid tube 52 constricts expansion in all but one direction. Thus, placing the optical signal sensor (not shown in FIG. 2C) adjacent the portion 54a of the tube 54 provides improved sensitivity.
Turning now to FIG. 3, there is shown a side, partial cross-sectional view of yet another embodiment of the present invention. The infusion set 60 includes a tube 64 disposed between the optical signal emitter (shown in shadow 68) and the optical signal receiver (shown in shadow 72) of the optical signal sensor 76. The portion 64a of the tube 64 disposed between the optical signal sensor 76 has a thin-walled portion on one side. Preferably, the thin-wall portion is between 0.025 and 0.050. The outer circumference of the tube 64 and will be between 0.175 and 0.300 thinner than the normal thickness of the tube 64. As pressure within the tube 64 changes, the thin-walled portion 64a will expand and contract to a greater extent. The exaggerated expansion and contraction provides increased sensitivity to pressure changes, as the optical signal sensor 76 can more readily detect pressure changes due to the exaggerated movement . Turning now to FIG. 4A, there is shown a side view of yet another embodiment of an optical sensor system made in accordance with the present invention and a portion of the tube of an infusion set passing therethrough. The tube 84 is disposed generally above an optical signal emitter 88 and an optical signal receiver 92 which form an optical signal sensor, generally indicated at 96.
The tube 84 is positioned in a generally planar configuration. However, a portion 84a of the tube 84 positioned above the space between the optical signal emitter 88 and the optical signal receiver 92 is engaged by an abutment member 100 so as to deflect that portion of the tube into the space 104 between the optical signal emitter 88 and the optical signal receiver 92.
The abutment member 100 serves two valuable functions. First, the abutment member 100 helps to ensure the tube 84 of the infusion set is in the desired location and helps resist movement of the tube which may be caused by the pump mechanism. Second, the abutment member 100 prevents expansion of the tube 84 along the top side thereof adjacent to the optical signal sensor 96. This causes pressure changes to expand and contract the opposing wall 84b of the tube in an exaggerated manner to how the sidewalls of the tube will normally respond to pressure changes. As with the embodiments discussed above, this exaggerated movement allows the optical signal sensor 96 to detect smaller changes in pressure, and thereby provide more accuracy in determining pressure changes within the infusion set. Turning now to FIG. 4B, there is shown a bottom view of the tube 84 of an infusion set 86 and the abutment member 100 as used in accordance with the principles of the present invention. In addition to the tube 84, the infusion set includes an upstream intake tube 86a and a downstream output tube 86b. The tube 84 of the infusion set has a looped portion 84c which wraps around the rotor (not shown) of an enteral feeding pump, or similar device. The abutment member 100 is disposed to engage the tube 84 of the infusion set 86 both upstream and downstream from the pump rotor. As will be discussed in additional detail below, pressure is monitored both upstream and downstream from the pump rotor to ensure that 1) a known quantity of solution reaches the portion of the tube 84 which engages the pump rotor, and 2) that the solution pumped by the pump rotor reaches the patient.
The tube 84 of the infusion set 86 is typically made from an elastomeric material such as silicone. This allows the tube 84 to stretch and to expand and contract is it is worked by the pump rotor to move solution through the tube. The remainder of the infusion set 86, however, need not be formed from silicone. To the contrary, less expensive tubing can be used for the remainder of the infusion set 86. The silicone tube 84 and the remainder of the infusion set 86 are typically held together by an adaptor 108 having two connectors 110. These connectors 110 can be formed as an integral, one piece adaptor including the abutment member 100, or can be formed separately. As the pump rotor rotates, a vacuum is created in the upstream portion 84d of the tube 84 of the infusion set. This vacuum will cause tube portion 84b along the upstream portion 84d to contract. The extent of contraction and the time necessary to return to ambient is a function of the viscosity of the solution upstream from the pump rotor and the presence of any occlusions. By monitoring the change in the diameter of the tube portion 84b upstream from the pump rotor, the enteral feeding pump is able to determine the viscosity and occlusion's effect on solution flow rate and thereby determine the amount of solution which is being pumped by each rotation of the pump rotor. This is typically done by monitoring the voltage produced by the optical signal receiver. The greater the voltage which is received, the greater the amount of light which is getting passed the tube portion 84b. If the monitored collapse of the tube portion 84b indicates that the viscosity is too great or that there is an occlusion, the voltage reading will be higher than expected and the enteral feeding pump can generate an alarm signal indicating that a predetermined threshold has been passed. Unlike the upstream portion 84d of the tube 84 of the infusion set 86, the downstream portion 84e will receive increased pressure with each rotation of the pump rotor, thereby causing the downstream portion 84b to expand. The expansion will restrict light flow from the optical signal emitter to the optical signal receiver, thereby decreasing the voltage generated. If the pressure increase lasts for too long a period of time or is too great, the optical signal sensor (not shown) will produce voltage readings indicative of the excess or prolonged expansion of portion 84b along the downstream portion 84e of the tube 84. The enteral feeding pump can then generate an alarm indicating an occlusion downstream. This will prevent the patient from being subject to sudden pressure increases which could cause discomfort or even injury. As mentioned with respect to FIG. 4A, the abutment member 100 increases the accuracy of the optical signal sensor 96 by exaggerating the expansion (downstream) or contraction (upstream) along the tube portion 84b. This exaggerated movement enables the enteral feeding pump to more accurately determine pressure by the voltage readings produced by the optical signal sensor.
Turning now to FIG. 4C, there is shown a cross- sectional view of the tube 84 of the infusion set 86, and fragmented views of the abutment members 100a and 100b. In the upstream portion 84d of the tube 84 of the infusion set 86, the monitored property is almost always contraction of the tube. To this end, it has been found preferable to have an abutment member 100a which forms a relatively narrow projection and extends into engaging contact with the exterior of the tube
84. Preferably, the end of the projection should have a thickness (i.e. a cross-section taken generally co- planar with the cross-section of the tube) with a radius which is 1/8 the diameter of the tube 84. The narrow projection formed by the abutment member 84a allows the outer edges of the tube 84 to move upward and downwardly. This has been found to increase sensitivity to the vacuum created within the upstream portion 84d of the tube 84, and thereby enables the voltage reading of the associated optical signal sensor to more accurately indicate the pressure within the tube .
Because the downstream portion 84e of the tube 84 generally monitors only pressures at ambient or greater, it is not necessary for the abutment member
100b to form such a protrusion. Rather, the abutment member 100b is generally broader and generally presses against the entire top of the tube 84 at the location adjacent the optical signal sensor. As the pressure in the downstream portion 84e of the tube 84 increases, the relatively flat abutment member 100b limits expansion of the tube upwardly, thereby causing exaggerated expansion on the opposing side 84b of the tube 84. While a relatively narrow protrusion 100a and a broad protrusion 100b are shown for the abutment members, those skilled in the art will appreciate that abutment members having a variety of cross-sections may be used. For example, FIG. 4D shows the cross- section of protrusions which are generally squared, semi-oval and triangular. Through routine experimentation, those skilled in the art will be able to determine appropriate voltage curves associated with the shape and the tubing to be used.
Turning now to FIG. 5, there is shown a perspective view of an enteral feeding pump, generally indicated at 130, formed in accordance with the principles of the present invention. The pump 130 includes a motor unit 134 with a digital readout 138 and a plurality of control buttons 142. The motor unit 134 controls a rotor 146, which has a plurality of rollers 150 (typically three) which are configured to engage the tube 84 of the infusion set 86. As the rotor 146 rotates, the rollers 150 selectively pinch off the tube 84 and push solution contained therein downstream. If no pressure changes where present, one could readily determine the amount of solution moved by the pump 130 by simply counting the rotations . The pressures within the infusion set 86, however, effect the amount of solution which is moved by each rotation of the rotor 146. By determining these pressures, one can quite accurately calculate the amount of fluid being pumped. Thus, it is important to track the upstream and downstream pressures in the infusion set 86.
As shown in FIG. 5, the connectors 110' which connect the intake tube 86a and output tube 86b of the infusion set 86 to the tube 84 are formed integrally with an anti-free flow device 160 which is disposed within the tube 84 in the form of an adaptor housing 164 which nests within a pair of channels 168 on the enteral feeding pump 130. The housing may also have integrally formed therein one or more abutment members similar to those discussed above. In the alternative, a cover 170 which is used to hold the housing 164 to the channels 168 of the enteral feeding pump 130 may have one or more abutment members 174 formed thereon. Closing the cover 170 causes the abutment member 174 to extend through an opening in the housing 164 and to engage the tube 84. The tube 84 is then automatically and properly positioned between the optical signal emitter and the optical signal receiver (not visible in FIG. 5) which are disposed along the channels 168.
Because the abutment member 174 will push the tube 84 into a position in which the tube partially obstructs optical signals in the optical signal sensor, a high voltage signal from the sensor will indicate that the tube 84 of the infusion set is not properly loaded, and/or that the cover 170 has not been properly closed. A catch 178 can be used to hold the cover 170 closed.
By using the digital display 138 or an auditory signal, the enteral feeding pump 130 can readily determine and display the amount of solution which is being pumped during a given amount of time. It can also develop a signal when thresholds are exceeded, and can indicate trends in increased or decreased viscosity if desired. Furthermore, if the pump has been set to deliver a predetermined amount of solution in a given time, the enteral feeding pump 130 is able to adjust the rotor frequency (i.e. the number of times the rotor 146 rotates in a given amount of time) to ensure the desired amount of solution has been delivered. Thus, the present invention is able to obtain the advantages set forth in U.S. Patent No .5 , 720, 721, without the need of using pressure transducers or other similar, costly devices. By utilizing the aspects of the present invention discussed above, an optical sensor can be used to provide highly accurate pressure and viscosity information while substantially lowering the cost of the enteral feeding pump. While numerous different embodiments of the present invention have been disclosed, those skilled in the art will appreciate numerous modifications which can be made without departing from the scope and spirit of the present invention. The appended claims are intended to cover such modifications.

Claims

CLAIMSWhat is claimed is :
1. A method for monitoring pressure in an infusion set for administering solution to a patient, the method comprising: selecting an optical signal sensor having an optical signal emitter and an optical signal receiver; and positioning a tube of an infusion set adjacent to the optical signal sensor so that changes in the diameter of the tube changes an amount of optical signals detected by the optical signal receiver.
2. The method according to claim 1, wherein the method comprises generating a voltage indicative of the obstruction of light caused by the tube of the infusion set and determining pressure in the infusion set from the voltage.
3. The method according to claim 1, wherein the method comprises positioning the tube of the infusion set so that the tube obstructs signals sent from the optical signal emitter to the optical signal receiver so long as the pressure within the tube of the infusion set does not fall below a predetermined threshold.
4. The method according to claim 3, further including positioning the tube in the optical signal sensor so that the tube always at least partially obstructs the transmission of optical signals from the optical signal emitter to the optical signal receiver.
5. The method according to claim 1, wherein the method comprises positioning the tube of the infusion set so that the tube does not obstruct all optical signals sent from the optical signal emitter to the optical signal receiver so long as the pressure within the tube of the infusion set does not exceed a predetermined threshold.
6. The method according to claim 1, wherein the method comprises positioning the tube of the infusion set in the optical signal sensor so that expansion of the infusion set will not completely obstruct the transmission of optical signals between the optical signal emitter and the optical signal receiver.
7. The method according to claim 1, wherein the method comprises selecting an infusion- set having a tube with a thin-walled portion and disposing the thin-walled portion between the optical emitter and the optical receiver.
8. The method according to claim 1, wherein the method comprises developing a voltage reading representing a change in side of the size of the tubing.
9. The method according to claim 1, wherein the method comprises forming the infusion set with a tube and a jacket disposed about the tube, the jacket having an opening therein.
10. The method according to claim 9, wherein the method further comprises positioning the opening in the jacket between the optical signal emitter and the optical signal receiver.
11. The method according to claim 1, wherein the method further comprises forming the infusion set from a piece of generally rigid tubing having an opening along a wall thereof, and a piece of flexible tube, the flexible tube covering the opening in the rigid tube.
12. The method according to claim 11, wherein the method further comprises positioning the opening in the rigid tube between the optical signal emitter and the optical signal receiver .
13. The method according to claim 1, wherein the method comprises disposing the tube in engagement with an abutment member for pushing the tube between the optical signal emitter and the optical signal receiver.
14. The method according to claim 13, wherein the method comprises pushing a portion of the tube engaging the abutment member downwardly into a position between the optical signal emitter and optical signal receiver.
15. The method according to claim 13, wherein method comprises holding the tube of the infusion in a plane, and positioning the abutment member to forces a portion of the infusion set out of said plane.
16. The method according to claim 13, wherein the abutment member is positioned to limit expansion of the tube in one direction and thereby cause exaggerated expansion of the tube in another direction.
17. The method according to claim 13 , wherein the abutment member has an end which engages the tube, and wherein the end has a radius which is smaller than the tube.
18. The method according to claim 17, wherein the tube has a radius, and wherein the method comprises selecting an abutment having an end with a radius which is l/8th the diameter of the tube taken generally parallel to the diameter of the tube.
19. The method according to claim 13, wherein the abutment member has a cross-section which is generally square.
20. The method according to claim 13, wherein the abutment member has a semi-oval cross-section.
21. The method according to claim 13, wherein the abutment member has a triangular cross-section.
22. The method according to claim 1, wherein the method comprises positioning the tube of the infusion set about a rotor of an infusion pump to divide the tube into an upstream portion and a drownstream portion.
23. The method according to claim 20, wherein the method further comprises using the optical signal sensor for monitoring the extent of contraction in the diameter of the tube in the upstream portion of the tube .
24. The method according to claim 20, wherein the method further comprises using the optical signal sensor for monitoring the extent of expansion in the diameter of the tube in the downstream portion of the tube.
25. The method according to claim 22, wherein the method comprises positioning an optical signal sensor adjacent the upstream portion of the tube and an optical signal sensor adjacent the downstream portion
26. An adapter for disposition along an infusion set, the adaptor comprising: a first connector for attaching an upstream portion of an infusion set to a tube configured for engaging a pump rotor; a second connector for attaching a downstream portion of an infusion set to the tube configured for engaging the pump rotor, the second connector being attached to the first connector; and an abutment member disposed adjacent to the first connector and the second connector, the abutment member being configured for deflecting a portion of the tube into a nonlinear position.
27. The adaptor according to claim 26, wherein the first connector is configured for receiving a tube of a known diameter at ambient pressure, and wherein the abutment member has a first portion having an end configured for engaging the tube, the first portion having an end having a cross-sectional diameter which is about l/8th the diameter of the tube, such that the end presses inwardly into the tube when the tube is attached to the first connector.
28. An infusion set for an enteral feeding pump comprising the adaptor of claim 26, and further comprising an upstream tube connected to the first adaptor, a downstream tube connected to the downstream adaptor, and a tube having two ends, one end being attached to the first connector and the other end being attached to the second adaptor .
29. An apparatus for infusing solution into a patient, the device comprising: an infusion pump having a rotor for moving solution through a tube; a infusion set having a tube engaged by the rotor of the infusion pump; at least one optical signal sensor disposed along the tube, the optical sensor having an optical signal emitter and an optical signal receiver disposed on a side of the tube opposite from the optical signal emitter, the optical signal sensor being configured to detect changes in the diameter of the tube.
30. The apparatus of claim 29, wherein the at least one optical signal sensor comprises a first optical signal sensor disposed along the tube upstream from the rotor, and a second optical signal sensor disposed along the tube downstream from the rotor.
31. The apparatus of claim 29, further comprising an abutment member disposed to engage and deflect the tube out of a planar flow-path.
32. The apparatus of claim 31, wherein infusion set has an upstream tube and a downstream tube attached to the tube by an adaptor, and wherein the abutment member is disposed on the adaptor.
33. The apparatus of claim 31, wherein the pump has a cover and wherein the abutment member is disposed on the cover such that closing the cover causes the abutment member to engage the tube.
34. The apparatus of claim 29, further comprising a jacket having an opening therein disposed about the tube .
35. The apparatus of claim 34, wherein the opening in the jacket is disposed between the optical signal emitter and the optical signal receiver.
36. The apparatus of claim 29, wherein the tube has a thin-walled portion, and wherein the thin-walled portion is disposed between the optical signal emitter and the optical signal receiver.
37. The apparatus of claim 29, wherein the tube includes a rigid portion with an opening along a sidewall thereof, and a resilient portion covering said opening .
38. The apparatus of claim 37, wherein the opening in the rigid portion is disposed between the optical signal emitter and the optical signal receiver.
39. An apparatus for monitoring pressure in an infusion set for administering a solution to a patient, comprising; an optical signal sensor having an optical signal emitter and an optical signal receiver; and a resilient tube positioned proximate said signal sensor, said optical signal emitter positioned to pass an optical signal at least partially over a surface of said tube to be received by said optical signal receiver.
40. An apparatus for monitoring pressure in an infusion set for administering a solution to a patient, comprising: a housing; an elongate flexible tube positioned within said housing; an abutment member positioned within said housing engaging a surface of said elongate flexible tube for substantially preventing expansion of said elongate flexible tube in the direction of said abutment member; and an optical signal sensor positioned adjacent said elongate flexible tube and opposite said abutment member for measuring expansion and contraction of said elongate flexible tube.
PCT/US2001/051498 2001-04-16 2001-12-12 Optical pressure monitoring system WO2002084336A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01273542.9A EP1381889B1 (en) 2001-04-16 2001-12-12 Optical pressure monitoring system
JP2002582033A JP4143414B2 (en) 2001-04-16 2001-12-12 Optical pressure monitoring device
AU2001297726A AU2001297726A1 (en) 2001-04-16 2001-12-12 Optical pressure monitoring system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/836,852 US6523414B1 (en) 2001-04-16 2001-04-16 Optical pressure monitoring system
US09/836,852 2001-04-16

Publications (2)

Publication Number Publication Date
WO2002084336A2 true WO2002084336A2 (en) 2002-10-24
WO2002084336A3 WO2002084336A3 (en) 2003-03-20

Family

ID=25272889

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/051498 WO2002084336A2 (en) 2001-04-16 2001-12-12 Optical pressure monitoring system

Country Status (8)

Country Link
US (4) US6523414B1 (en)
EP (2) EP1381889B1 (en)
JP (2) JP4143414B2 (en)
CN (1) CN1221795C (en)
AU (1) AU2001297726A1 (en)
DK (1) DK2570826T3 (en)
ES (1) ES2603502T3 (en)
WO (1) WO2002084336A2 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008144693A1 (en) * 2007-05-21 2008-11-27 M2 Group Holdings, Inc. Occlusion sensing for an infusion pump
GB2469820A (en) * 2009-04-28 2010-11-03 Haemair Ltd Fluid Pressure Sensing Device
WO2011008624A3 (en) * 2009-07-13 2011-03-10 Nestec S.A. Infusion cassette and set for enteral feeding pump
US9610404B2 (en) 2011-09-07 2017-04-04 Bigfoot Biomedical, Inc. Method for occlusion detection for an infusion pump system
US9919096B2 (en) 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US9956339B2 (en) 2013-06-03 2018-05-01 Bigfoot Biomedical, Inc. Infusion pump system and method
US9962482B2 (en) 2007-05-21 2018-05-08 Bigfoot Biomedical, Inc. Removable controller for an infusion pump
US10064993B2 (en) 2005-09-26 2018-09-04 Bigfoot Biomedical, Inc. Dispensing fluid from an infusion pump system
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
USD836769S1 (en) 2016-12-12 2018-12-25 Bigfoot Biomedical, Inc. Insulin delivery controller
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
US10426896B2 (en) 2016-09-27 2019-10-01 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US10987468B2 (en) 2016-01-05 2021-04-27 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
US11147914B2 (en) 2013-07-19 2021-10-19 Bigfoot Biomedical, Inc. Infusion pump system and method
US11389088B2 (en) 2017-07-13 2022-07-19 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information
US11471598B2 (en) 2015-04-29 2022-10-18 Bigfoot Biomedical, Inc. Operating an infusion pump system
US11865299B2 (en) 2008-08-20 2024-01-09 Insulet Corporation Infusion pump systems and methods

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150727B2 (en) * 2000-05-11 2006-12-19 Zevex, Inc. Apparatus and method for preventing free flow in an infusion line
US7815612B2 (en) * 2000-05-11 2010-10-19 Zevex, Inc. Apparatus and method for preventing free flow in an infusion line
US6595950B1 (en) * 2000-05-11 2003-07-22 Zevex, Inc. Apparatus and method for preventing free flow in an infusion line
EP1229244A1 (en) * 2001-01-31 2002-08-07 Precimedix S.A. Occlusion detector for a peristaltic pump
US6523414B1 (en) * 2001-04-16 2003-02-25 Zevex, Inc. Optical pressure monitoring system
US6659976B2 (en) * 2001-04-16 2003-12-09 Zevek, Inc. Feeding set adaptor
US6893414B2 (en) * 2002-08-12 2005-05-17 Breg, Inc. Integrated infusion and aspiration system and method
US20050267401A1 (en) * 2004-05-25 2005-12-01 Sherwood Services, Ag. Safety interlock system for an enteral feeding pump
US7537579B2 (en) * 2002-09-26 2009-05-26 Covidien Ag Safety interlock system for an enteral feeding pump
AU2003300210A1 (en) * 2002-12-30 2004-07-29 James Brugger Pressure detector for fluid circuits
JP4356070B2 (en) * 2003-04-02 2009-11-04 セイコーエプソン株式会社 Liquid ejector
DE102004001915B3 (en) * 2004-01-14 2005-11-03 Festo Ag & Co. Method and device for monitoring the function of valves
WO2005102193A2 (en) * 2004-04-19 2005-11-03 Acumed, Llc Placement of fasteners into bone
US7092797B2 (en) * 2004-05-25 2006-08-15 Sherwood Services Ag Flow monitoring system for a flow control apparatus
KR100859653B1 (en) 2004-05-25 2008-09-23 코비디엔 아게 Flow monitoring system for a flow control apparatus
WO2006042012A2 (en) * 2004-10-05 2006-04-20 Airpax Corporation, Llc Pressure sensor
US7501596B2 (en) * 2005-06-27 2009-03-10 Evapco, Inc. Dimension sensor and method for stopping expansion of a tube
US7337674B2 (en) * 2005-06-29 2008-03-04 Nx Stage Medical, Inc. Pressure detector for fluid circuits
EP1933901B1 (en) 2005-09-26 2014-12-31 Asante Solutions, Inc. Portable infusion pump having a flexible pushrod with hinged portions
US7846131B2 (en) 2005-09-30 2010-12-07 Covidien Ag Administration feeding set and flow control apparatus with secure loading features
EP1772162A1 (en) * 2005-10-08 2007-04-11 Boehringer Mannheim Gmbh Infusion system for delivery of a liquid drug
US8092414B2 (en) 2005-11-09 2012-01-10 Nxstage Medical, Inc. Diaphragm pressure pod for medical fluids
DK1818664T3 (en) 2006-02-13 2013-08-05 Hoffmann La Roche Apparatus for recognizing a pressure change in the liquid path of a micro-dosing device
US7927304B2 (en) 2006-03-02 2011-04-19 Tyco Healthcare Group Lp Enteral feeding pump and feeding set therefor
US7763005B2 (en) 2006-03-02 2010-07-27 Covidien Ag Method for using a pump set having secure loading features
US7722562B2 (en) 2006-03-02 2010-05-25 Tyco Healthcare Group Lp Pump set with safety interlock
US8021336B2 (en) 2007-01-05 2011-09-20 Tyco Healthcare Group Lp Pump set for administering fluid with secure loading features and manufacture of component therefor
US7722573B2 (en) * 2006-03-02 2010-05-25 Covidien Ag Pumping apparatus with secure loading features
ES2751017T3 (en) * 2006-06-08 2020-03-30 Hoffmann La Roche System to detect an occlusion in a tube
US7805978B2 (en) 2006-10-24 2010-10-05 Zevex, Inc. Method for making and using an air bubble detector
US8087019B1 (en) 2006-10-31 2011-12-27 Aol Inc. Systems and methods for performing machine-implemented tasks
US7560686B2 (en) * 2006-12-11 2009-07-14 Tyco Healthcare Group Lp Pump set and pump with electromagnetic radiation operated interlock
US7840102B2 (en) * 2007-01-16 2010-11-23 Baker Hughes Incorporated Distributed optical pressure and temperature sensors
US7833196B2 (en) 2007-05-21 2010-11-16 Asante Solutions, Inc. Illumination instrument for an infusion pump
EP2022519A1 (en) * 2007-08-10 2009-02-11 F. Hoffmann-La Roche AG Device for detecting a pressure change in the liquid path of a micro dosing apparatus
US7987722B2 (en) * 2007-08-24 2011-08-02 Zevex, Inc. Ultrasonic air and fluid detector
CA2903692A1 (en) * 2008-04-01 2009-10-08 Zevex, Inc. Anti-free flow mechanism for enteral feeding pumps
US8425470B2 (en) 2008-04-01 2013-04-23 Zevex, Inc. Anti-free-flow mechanism for enteral feeding pumps
EP2349405B1 (en) 2008-09-22 2019-11-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for determining at least one flow parameter
US20100114063A1 (en) * 2008-11-04 2010-05-06 Angiodynamics, Inc. Catheter injection monitoring device
WO2010091314A2 (en) 2009-02-06 2010-08-12 Zevex, Inc. Air bubble detector
US7998121B2 (en) * 2009-02-06 2011-08-16 Zevex, Inc. Automatic safety occluder
US20100211002A1 (en) * 2009-02-18 2010-08-19 Davis David L Electromagnetic infusion pump with integral flow monitor
US8197235B2 (en) * 2009-02-18 2012-06-12 Davis David L Infusion pump with integrated permanent magnet
US8353864B2 (en) * 2009-02-18 2013-01-15 Davis David L Low cost disposable infusion pump
US8770010B1 (en) 2009-03-30 2014-07-08 Strain Measurement Devices, Inc. Integrated detector for detecting bubbles in fluid flow and occlusions in a tube
CN102427835B (en) * 2009-05-19 2014-07-02 德国弗雷泽纽斯医疗保健股份有限公司 Apparatus and method for identifying a tubing system for an extracorporeal blood treatment device
ES2621464T3 (en) * 2009-07-13 2017-07-04 Nestec S.A. Cassette provided with an infusion set, containing an anti-reflux ball valve, for a peristaltic infusion pump
CN102548597B (en) * 2009-08-26 2017-03-22 雀巢产品技术援助有限公司 Infra-red reflective occlusion sensors
US8287488B2 (en) 2009-12-08 2012-10-16 Roche Diagnostics Operations, Inc. Holographic occlusion detection system for infusion pumps
US9151646B2 (en) 2011-12-21 2015-10-06 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US8154274B2 (en) 2010-05-11 2012-04-10 Tyco Healthcare Group Lp Safety interlock
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8486020B2 (en) 2010-08-11 2013-07-16 Zevex, Inc. Pressure sensor and method of use
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
US8377000B2 (en) * 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
EP2621556B1 (en) 2010-10-01 2020-06-10 Zevex, Inc. Method for improving accuracy in a peristaltic pump system based on tubing material properties
USD672455S1 (en) 2010-10-01 2012-12-11 Zevex, Inc. Fluid delivery cassette
JP2013538650A (en) 2010-10-01 2013-10-17 ゼヴェクス・インコーポレーテッド Pressure monitoring system for infusion pumps
CN103298506B (en) 2010-10-01 2016-05-04 泽维克斯公司 Anti-free-pouring plugging device and infusion actuation pad
CA2812551C (en) 2010-10-01 2015-06-09 Zevex, Inc. Pressure sensor seal and method of use
US9551625B2 (en) 2011-05-31 2017-01-24 Nxstage Medical, Inc. Pressure measurement devices, methods, and systems
US10488848B2 (en) 2011-12-21 2019-11-26 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US9746094B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Flow meter having a background pattern with first and second portions
US9435455B2 (en) 2011-12-21 2016-09-06 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US9724466B2 (en) 2011-12-21 2017-08-08 Deka Products Limited Partnership Flow meter
US10228683B2 (en) 2011-12-21 2019-03-12 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US9372486B2 (en) 2011-12-21 2016-06-21 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US9746093B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Flow meter and related system and apparatus
DE102012102274B4 (en) * 2012-03-19 2018-05-24 B. Braun Melsungen Ag piston pump
DE102012102273A1 (en) * 2012-03-19 2013-09-19 B. Braun Melsungen Ag Device for feeding and dosing a fluid for medical purposes
WO2013160333A2 (en) * 2012-04-24 2013-10-31 Novo Nordisk A/S Drug delivery device and method for detection of an end-of-dose condition
US8454562B1 (en) 2012-07-20 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US9710610B2 (en) 2012-07-25 2017-07-18 Covidien Lp Enteral feeding pump with flow adjustment
US10842932B1 (en) * 2012-08-08 2020-11-24 Neurowave Systems Inc. Intelligent pharmaceutical delivery system with non-concentric pumping mechanism to reduce flow anomaly and method of using
US9759343B2 (en) 2012-12-21 2017-09-12 Deka Products Limited Partnership Flow meter using a dynamic background image
KR102235689B1 (en) * 2013-07-30 2021-04-02 삼성전자주식회사 Liquid occlusion detection apparatus and method
MX2016003426A (en) 2013-09-24 2016-06-28 Covidien Lp Feeding set and enteral feeding pump.
USD749206S1 (en) 2013-11-06 2016-02-09 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD745661S1 (en) 2013-11-06 2015-12-15 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD751689S1 (en) 2013-11-06 2016-03-15 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD751690S1 (en) 2013-11-06 2016-03-15 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD752209S1 (en) 2013-11-06 2016-03-22 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD739931S1 (en) * 2013-11-30 2015-09-29 Zevex, Inc. Enteral feeding pump cassette
USD735320S1 (en) * 2013-11-30 2015-07-28 Zevex, Inc. Enteral feeding pump cassette
US10080836B2 (en) 2014-01-23 2018-09-25 Zevex, Inc. Absorption-based optical sensor for detecting infusion pump cassette
USD743023S1 (en) 2014-04-15 2015-11-10 Zevex, Inc. Enteral feeding pump interface
WO2016161060A1 (en) * 2015-04-03 2016-10-06 Orczy-Timko Benedek Surgical fluid management system
EP3377145A1 (en) * 2015-11-16 2018-09-26 onefusion AG Procedure to operate a perfusion device and perfusion device to implement the procedure
USD905848S1 (en) 2016-01-28 2020-12-22 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
SG11201806463SA (en) 2016-01-28 2018-08-30 Deka Products Lp Apparatus for monitoring, regulating, or controlling fluid flow
USD809134S1 (en) 2016-03-10 2018-01-30 Bigfoot Biomedical, Inc. Infusion pump assembly
USD854145S1 (en) 2016-05-25 2019-07-16 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
ES2960055T3 (en) 2016-06-16 2024-02-29 Smiths Medical Asd Inc Sets and Methods for Infusion Pump System Administration Sets
EP3554355A1 (en) 2016-12-15 2019-10-23 Baxter International Inc System and method for monitoring and determining patient parameters from sensed venous waveform
AU2018302257A1 (en) 2017-07-19 2020-01-30 Smiths Medical Asd, Inc. Housing arrangements for infusion pumps
US11504471B2 (en) 2018-04-12 2022-11-22 Diatech Diabetes, Inc. Systems and methods for detecting disruptions in fluid delivery devices
US11039754B2 (en) 2018-05-14 2021-06-22 Baxter International Inc. System and method for monitoring and determining patient parameters from sensed venous waveform
US11213460B2 (en) 2018-09-19 2022-01-04 Vesco Medical Llc Connectors for infusion pump feeding sets
US10794786B2 (en) 2018-09-24 2020-10-06 Honeywell International Inc. Miniature size force sensor with bubble detection capabilities
EP3705148A1 (en) 2019-03-04 2020-09-09 Avoset Health Ltd. In cycle pressure measurement
WO2020178827A1 (en) 2019-03-05 2020-09-10 Avoset Health Ltd. Anti-free-flow valve
USD964563S1 (en) 2019-07-26 2022-09-20 Deka Products Limited Partnership Medical flow clamp
WO2021021596A1 (en) 2019-07-26 2021-02-04 Deka Products Limited Partnership Apparatus for monitoring, regulating, or controlling fluid flow
CN115279433B (en) * 2020-03-11 2024-02-27 泰尔茂株式会社 Detection device and infusion pump
US11506556B2 (en) * 2020-09-30 2022-11-22 Rosenmount Inc. Single-use plastic pressure sensor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176631A (en) * 1989-09-05 1993-01-05 Pacesetter Infusion, Ltd. Ultrasonic air-in-line detector for detecting entrained air in a medication infusion system
US5657000A (en) * 1995-06-02 1997-08-12 Cobe Laboratories, Inc. Peristaltic pump occlusion detector and adjuster
US5860938A (en) * 1996-03-07 1999-01-19 Scimed Life Systems, Inc. Medical pressure sensing guide wire

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994599A (en) 1974-01-23 1976-11-30 Owens-Illinois, Inc. Method and apparatus for measuring wall thickness and concentricity of tubular glass articles
US3978731A (en) * 1974-02-25 1976-09-07 United Technologies Corporation Surface acoustic wave transducer
US4244365A (en) 1979-03-26 1981-01-13 Cutter Laboratories, Inc. Device for use in detecting occlusion in an infusion system
JPS5631758A (en) 1979-08-24 1981-03-31 Sharp Kk Detector for clogging condition of flexible tube
DE2937511A1 (en) 1979-09-17 1981-05-07 Siemens AG, 1000 Berlin und 8000 München OPTICAL DEVICE FOR MEASURING LOW PRESSURE DIFFERENCES BY MEANS OF LIGHT INTENSITY CHANGE
DE2937484A1 (en) 1979-09-17 1981-05-14 Siemens AG, 1000 Berlin und 8000 München OPTICAL DEVICE FOR MEASURING PRESSURE DIFFERENCES BY LIGHT INTENSITY CHANGE
JPS56113083A (en) 1980-02-12 1981-09-05 Terumo Corp Choke detection method and device for peristaltic liquid pump
JPS58163860A (en) 1982-03-23 1983-09-28 Nissan Motor Co Ltd Oil seal lubricating system in transmission
US4492463A (en) 1982-03-29 1985-01-08 At&T Bell Laboratories Method for inspecting multilayer transparent rods
JPS58163860U (en) * 1982-04-28 1983-10-31 シャープ株式会社 Blockage detection device for flexible tubes
US4606638A (en) 1983-11-03 1986-08-19 Zygo Corporation Distance measuring interferometer and method of use
US4618261A (en) 1984-01-16 1986-10-21 Massachusetts Institute Of Technology Optical gap measuring
DE3405026A1 (en) 1984-02-13 1985-08-14 Philips Patentverwaltung Gmbh, 2000 Hamburg OPTICAL PRESSURE SENSOR
US4554837A (en) 1984-05-04 1985-11-26 Anatros Corporation Reflective optical fluid pressure sensor
US4555949A (en) 1984-05-04 1985-12-03 Anatros Corporation Optical fluid pressure sensor
GB8424101D0 (en) 1984-09-24 1984-10-31 Vi Tal Hospital Products Ltd Air-in-line detector
US4631529A (en) 1984-10-17 1986-12-23 Ivek Corporation Electro-optical fluid detector
US4624413A (en) * 1985-01-23 1986-11-25 Corsette Douglas Frank Trigger type sprayer
US4762518A (en) 1986-08-01 1988-08-09 Pancretec, Inc. Blockage hazard alarm in an intravenous system
GB8622988D0 (en) 1986-09-24 1986-10-29 Westland Plc Joining thermoplastic materials
US4833918A (en) 1986-09-24 1989-05-30 Cannonbear, Inc. Sensor and method for ullage level and flow detection
EP0261860B1 (en) 1986-09-24 1992-12-16 Cannonbear Inc. Sensor and method for ullage level and flow detection
US4882575A (en) * 1987-01-28 1989-11-21 Sharp Kabushiki Kaisha Monitor for blocked condition in tube for fluid infusion pump
US4908676A (en) 1987-12-18 1990-03-13 Bio-Recovery Systems, Inc. Sensors for dissolved substances in fluids
FR2628635B1 (en) * 1988-03-21 1992-10-23 Microtechnic Sa SINGLE USE SYRINGE
JPH01249064A (en) 1988-03-30 1989-10-04 Nikkiso Co Ltd Detection of closed state of infusion pipe and device therefor
US5074756A (en) 1988-05-17 1991-12-24 Patient Solutions, Inc. Infusion device with disposable elements
JPH021805A (en) 1988-06-10 1990-01-08 Nec Corp Light transmission/reception module
US4920336A (en) * 1988-11-22 1990-04-24 Fisher Scientific Company Method and apparatus for monitoring the level of the contents in a container
US5008556A (en) 1989-07-24 1991-04-16 Becton, Dickinson And Company Measuring a gap between a tube and a float
US5029621A (en) 1990-04-12 1991-07-09 Clintec Nutrition Co. Push back procedure for preventing drop-former droplet formation in a vacuum assisted solution transfer system with upstream occulusion
US5260665A (en) 1991-04-30 1993-11-09 Ivac Corporation In-line fluid monitor system and method
US5305237A (en) 1991-07-12 1994-04-19 Union Tank Car Company Method and apparatus for monitoring a flowable material in a transportable vessel
US5181912A (en) * 1991-12-05 1993-01-26 Roy Hammett Non-reusable syringe
DK48092D0 (en) 1992-04-10 1992-04-10 Novo Nordisk As APPARATUS
US5695473A (en) 1994-07-27 1997-12-09 Sims Deltec, Inc. Occlusion detection system for an infusion pump
GB9422826D0 (en) * 1994-11-11 1995-01-04 Spraysol Gmbh Dispenser for liquid products
US6290681B1 (en) * 1994-12-20 2001-09-18 Remote Medical Corporation Flow monitoring device for medical application
US5445622A (en) * 1994-12-20 1995-08-29 Brown; Eric W. Flow switch device for medical applications
US5514102A (en) * 1995-05-05 1996-05-07 Zevex Incorporated Pressure monitoring enteral feeding system and method
US5672887A (en) * 1995-11-29 1997-09-30 Shaw; Benjamin G. Optical detector for air in fluid line the same
DE19616952C1 (en) 1996-04-27 1997-01-23 Karlsruhe Forschzent Tactile optoelectronic pressure sensor
JP3634071B2 (en) * 1996-05-29 2005-03-30 株式会社吉野工業所 Trigger type ejector return spring device
US5853386A (en) * 1996-07-25 1998-12-29 Alaris Medical Systems, Inc. Infusion device with disposable elements
US5964377A (en) * 1997-10-14 1999-10-12 S. C. Johnson & Son, Inc. Manually operable pump for mixing and dispensing primary and secondary fluids
US6490931B1 (en) * 1998-12-04 2002-12-10 Weatherford/Lamb, Inc. Fused tension-based fiber grating pressure sensor
WO2000037914A2 (en) * 1998-12-04 2000-06-29 Cidra Corporation Bragg grating pressure sensor
US6116472A (en) * 1998-12-15 2000-09-12 Calmar Inc. Trigger acutated pump sprayer
US6463813B1 (en) * 1999-06-25 2002-10-15 Weatherford/Lamb, Inc. Displacement based pressure sensor measuring unsteady pressure in a pipe
US6595950B1 (en) 2000-05-11 2003-07-22 Zevex, Inc. Apparatus and method for preventing free flow in an infusion line
US7815612B2 (en) 2000-05-11 2010-10-19 Zevex, Inc. Apparatus and method for preventing free flow in an infusion line
US7150727B2 (en) 2000-05-11 2006-12-19 Zevex, Inc. Apparatus and method for preventing free flow in an infusion line
US6659976B2 (en) 2001-04-16 2003-12-09 Zevek, Inc. Feeding set adaptor
US6523414B1 (en) 2001-04-16 2003-02-25 Zevex, Inc. Optical pressure monitoring system
US6531708B1 (en) 2001-04-16 2003-03-11 Zevex, Inc. Optical bubble detection system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176631A (en) * 1989-09-05 1993-01-05 Pacesetter Infusion, Ltd. Ultrasonic air-in-line detector for detecting entrained air in a medication infusion system
US5657000A (en) * 1995-06-02 1997-08-12 Cobe Laboratories, Inc. Peristaltic pump occlusion detector and adjuster
US5860938A (en) * 1996-03-07 1999-01-19 Scimed Life Systems, Inc. Medical pressure sensing guide wire

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1381889A2 *

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10064993B2 (en) 2005-09-26 2018-09-04 Bigfoot Biomedical, Inc. Dispensing fluid from an infusion pump system
WO2008144693A1 (en) * 2007-05-21 2008-11-27 M2 Group Holdings, Inc. Occlusion sensing for an infusion pump
US9962482B2 (en) 2007-05-21 2018-05-08 Bigfoot Biomedical, Inc. Removable controller for an infusion pump
US9717849B2 (en) 2007-05-21 2017-08-01 Bigfoot Biomedical, Inc. Occlusion sensing for an infusion pump
US11865299B2 (en) 2008-08-20 2024-01-09 Insulet Corporation Infusion pump systems and methods
GB2469820A (en) * 2009-04-28 2010-11-03 Haemair Ltd Fluid Pressure Sensing Device
US8986252B2 (en) 2009-07-13 2015-03-24 Nestec S.A. Cassettes and methods of using same
WO2011008624A3 (en) * 2009-07-13 2011-03-10 Nestec S.A. Infusion cassette and set for enteral feeding pump
US9610404B2 (en) 2011-09-07 2017-04-04 Bigfoot Biomedical, Inc. Method for occlusion detection for an infusion pump system
US9956339B2 (en) 2013-06-03 2018-05-01 Bigfoot Biomedical, Inc. Infusion pump system and method
US11147914B2 (en) 2013-07-19 2021-10-19 Bigfoot Biomedical, Inc. Infusion pump system and method
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US11464906B2 (en) 2013-12-02 2022-10-11 Bigfoot Biomedical, Inc. Infusion pump system and method
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
US10994078B2 (en) 2014-08-06 2021-05-04 Bigfoot Biomedical, Inc. Infusion pump assembly and method
US9919096B2 (en) 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US10661008B2 (en) 2014-08-26 2020-05-26 Bigfoot Biomedical, Inc. Infusion pump system and method
US11471598B2 (en) 2015-04-29 2022-10-18 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10987468B2 (en) 2016-01-05 2021-04-27 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
US10426896B2 (en) 2016-09-27 2019-10-01 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
US11229751B2 (en) 2016-09-27 2022-01-25 Bigfoot Biomedical, Inc. Personalizing preset meal sizes in insulin delivery system
US11806514B2 (en) 2016-09-27 2023-11-07 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
USD836769S1 (en) 2016-12-12 2018-12-25 Bigfoot Biomedical, Inc. Insulin delivery controller
USD852837S1 (en) 2017-06-16 2019-07-02 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
US11389088B2 (en) 2017-07-13 2022-07-19 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information

Also Published As

Publication number Publication date
ES2603502T3 (en) 2017-02-27
WO2002084336A3 (en) 2003-03-20
US7121143B2 (en) 2006-10-17
EP2570826A3 (en) 2013-08-21
CN1221795C (en) 2005-10-05
JP2008220982A (en) 2008-09-25
CN1494651A (en) 2004-05-05
JP4143414B2 (en) 2008-09-03
EP2570826B1 (en) 2016-08-31
DK2570826T3 (en) 2016-12-19
EP2570826A2 (en) 2013-03-20
US7921718B2 (en) 2011-04-12
EP1381889B1 (en) 2016-03-16
JP2004531314A (en) 2004-10-14
US20050178206A1 (en) 2005-08-18
US20070151346A1 (en) 2007-07-05
JP4921413B2 (en) 2012-04-25
US6907788B2 (en) 2005-06-21
AU2001297726A1 (en) 2002-10-28
EP1381889A4 (en) 2008-07-02
US6523414B1 (en) 2003-02-25
US20030070486A1 (en) 2003-04-17
EP1381889A2 (en) 2004-01-21

Similar Documents

Publication Publication Date Title
EP2570826B1 (en) Optical pressure monitoring system
EP2596819B1 (en) Feeding set adaptor
AU737494B2 (en) Infusion device with disposable elements
US5514102A (en) Pressure monitoring enteral feeding system and method
EP2621557B1 (en) Pressure sensor seal
US5688244A (en) Apparatus for monitoring infusion
JPH01308570A (en) Patient side closure detection system for drug injection system
AU2001238698A1 (en) Force sensor assembly for an infusion pump
AU2020259427A1 (en) Medical tubing dimension scanning
CN114302751A (en) System and method for post-occlusion dose reduction
CN115916288A (en) Infusion pump sensing system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001273542

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 018231381

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2002582033

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001273542

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642